Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Five9, Inc. [1] Group 1: Shareholder Rights and Options - Long-term shareholders of Five9 may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [2] - Shareholder involvement is crucial for improving company policies and enhancing shareholder value [3] Group 2: Legal Representation and Achievements - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, recovering millions for defrauded investors [4]

Core Viewpoint - NuScale Power Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding their commercialization partnership with ENTRA1 Energy LLC and the capabilities of ENTRA1 in the nuclear power sector [1][3]. Company Overview - NuScale Power Corporation specializes in small modular nuclear reactors, specifically the NuScale Power Module (NPM), aimed at generating energy within larger power plants [2]. - The company entered a global commercialization partnership with ENTRA1 Energy LLC, which was expected to facilitate the deployment of its NPM technology [2]. Allegations and Financial Impact - The lawsuit alleges that NuScale and its executives failed to disclose critical information about ENTRA1's lack of experience in building or operating significant nuclear projects, which posed undisclosed risks to NuScale's commercialization strategy [3]. - On November 6, 2025, NuScale reported a dramatic increase in general and administrative expenses, which surged over 3,000% to $519 million from $17 million in the previous year, primarily due to a $495 million payment to ENTRA1 [4]. - The company's quarterly net loss also increased significantly to $532 million from $46 million year-over-year, leading to a more than 12% decline in NuScale Class A shares over a two-day trading period following the announcement [4]. Legal Process - Investors who purchased NuScale Class A common stock during the specified class period can seek appointment as lead plaintiff in the class action lawsuit, which allows them to represent the interests of all class members [6]. Law Firm Background - Robbins Geller Rudman & Dowd LLP, the law firm representing the plaintiffs, is recognized as a leading firm in securities fraud litigation, having recovered over $916 million for investors in 2025 alone [7].

Core Viewpoint - Camping World Holdings, Inc. is facing a class action lawsuit due to significant financial losses reported in Q3 and Q4 of 2025, which led to a substantial decline in stock prices and alleged misleading statements by the company regarding its business operations and financial health [1]. Financial Performance - In Q3 2025, Camping World reported a decrease in new vehicle revenue by $58.1 million, or 7.0%, and an 8.6% drop in the average selling price of new vehicles, with total gross margin decreasing by 27 basis points [1]. - The company projected a low $300 million range for Adjusted EBITDA growth in 2026 [1]. - In Q4 2025, Camping World reported a net loss of $(109.1) million, an increase of $49.6 million, or 83.3%, and an adjusted EBITDA loss of $(26.2) million, worsening by $23.7 million [1]. - Gross profit for Q4 2025 was $338.2 million, down by $38.7 million, or 10.3%, with total gross margin at 28.8%, a decrease of 247 basis points [1]. Stock Market Reaction - Following the Q3 2025 results announcement, Camping World's stock fell by $4.17, or 24.8%, closing at $12.65 per share [1]. - After the Q4 2025 results were released, the stock price dropped by $1.79, or 16.5%, to close at $9.06 per share [1]. Lawsuit Details - The class action lawsuit alleges that the company made materially false and misleading statements and failed to disclose adverse facts about its business and operations [1]. - Specific allegations include overstating inventory management capabilities, retail demand, and the adequacy of systems for accurate disclosures [1]. - Investors who purchased Camping World securities during the specified class period are encouraged to participate in the lawsuit, with a deadline to file a lead plaintiff motion by May 11, 2026 [1].

Core Viewpoint - The lawsuit against BellRing Brands, Inc. alleges that the company and its executives misled investors regarding the true drivers of its sales growth, which was primarily due to retailers hoarding inventory rather than genuine consumer demand [3][5]. Group 1: Allegations and Misleading Statements - The lawsuit claims that BellRing's reported sales growth in 2025 was not reflective of actual consumer demand but was instead driven by retailers stockpiling inventory to avoid previous supply chain shortages [3][7]. - Following the revelation of these practices, BellRing's share price experienced a significant decline, including a 33% drop in a single day after disappointing financial results were reported [3][7]. Group 2: Financial Impact and Market Reaction - On May 6, 2025, BellRing's CFO acknowledged that several key retailers had been hoarding inventory, which led to a 19% drop in share price after the announcement [7]. - The Q3 2025 financial results, reported on August 4, 2025, indicated a narrowed sales outlook and increased competition, resulting in a further 33% decline in share price [7]. Group 3: Legal Proceedings and Next Steps - The lead plaintiff deadline for the lawsuit is set for March 23, 2026, and investors who suffered losses during the specified period are encouraged to participate [1][6]. - Hagens Berman, the law firm handling the case, is actively seeking investors who purchased shares between November 19, 2024, and August 4, 2025, to join the litigation [6].

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Nektar Therapeutics (NASDAQ: NKTR) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Nektar securities between February 26, 2025 and December 25, 2025, bot ...

Core Viewpoint - A class action lawsuit has been filed against Driven Brands Holdings Inc. and certain officers for alleged violations of federal securities laws, impacting investors who acquired Driven Brands securities between May 9, 2023, and February 24, 2026 [1][2]. Summary by Sections Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Driven Brands securities during the specified class period [2]. - Allegations include materially false and misleading statements made by the defendants regarding the company's financial condition and internal controls [3]. Allegations Against Driven Brands - The complaint claims that the company's financial condition was misrepresented in inaccurate financial reports filed with the SEC from May 9, 2023, to November 5, 2025 [3]. - It is alleged that the company lacked effective internal controls over financial reporting during this period [3]. - The balance sheets reportedly included an unreconciled cash balance from 2023, leading to overstated revenue and cash for fiscal years 2023 and 2024 [3]. - Additionally, the company is accused of understating operating expenses during the same timeframe [3]. - As a result of these issues, public statements regarding the company's financial condition and internal controls were deemed materially false and misleading [3]. Next Steps for Investors - Investors wishing to join the class action have until May 8, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this role [4]. - A copy of the complaint can be reviewed on the law firm's website [4]. Legal Representation - Bronstein, Gewirtz & Grossman LLC operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful in the lawsuit [5]. - The firm has a history of recovering significant amounts for investors in securities fraud cases [6].

Core Viewpoint - The monday.com class action lawsuit alleges that the company and its executives made misleading statements regarding the company's financial outlook and growth potential, leading to significant stock price declines [1][4][5]. Group 1: Lawsuit Details - The lawsuit, titled Potter v. monday.com Ltd., seeks to represent purchasers of monday.com common stock and accuses the company of violating the Securities Exchange Act of 1934 [1]. - The class action claims that defendants created a false impression of reliable revenue projections and growth, despite signs of decelerating customer growth and longer sales cycles [4]. - On February 9, 2026, monday.com announced a shift in focus from its 2027 targets to its 2026 outlook, resulting in a nearly 21% drop in stock price [5]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased monday.com stock during the Class Period to seek appointment as lead plaintiff [6]. - The lead plaintiff represents the interests of all class members and can select a law firm to litigate the case [6]. Group 3: Company Background - monday.com develops software applications and has been focusing on AI-driven investments and enterprise adoption [3][4]. - The company had set a revenue target of $1.8 billion for 2027, which is now considered increasingly unlikely to be met due to the issues raised in the lawsuit [4].

Core Viewpoint - A class action lawsuit has been filed against Mereo BioPharma Group plc on behalf of investors who purchased its American Depositary Shares during the specified class period, alleging misleading information regarding clinical study results [1][3]. Group 1: Lawsuit Details - The lawsuit is initiated by Berger Montague PC, representing investors who bought Mereo ADS from June 5, 2023, to December 26, 2025 [1][2]. - Investors have until April 6, 2026, to seek appointment as lead plaintiff representative of the class [2]. Group 2: Allegations Against Mereo - The complaint states that Mereo misled investors by raising expectations about the ORBIT and COSMIC studies, which tested setrusumab for Osteogenesis Imperfecta, while concealing that neither study significantly reduced clinical fracture rates compared to control groups [3]. - Following the disclosure of the study results, Mereo's ADS price fell from $2.31 on December 26, 2025, to $0.29 on December 29, resulting in a loss of over 87.7% of its value in one day [3].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Kyndryl Holdings, Inc. for alleged material misstatements and omissions regarding its financial practices and internal controls during the specified class period [2][4]. Group 1: Lawsuit Details - The lawsuit is filed on behalf of investors who purchased Kyndryl securities between August 7, 2024, and February 9, 2026, and is pending in the United States District Court for the Eastern District of New York [2][6]. - Investors have until April 13, 2026, to file for lead plaintiff status in the lawsuit [6][7]. - The key allegations include that Kyndryl's financial statements were materially misstated and that the company lacked adequate internal controls [4][6]. Group 2: Stock Performance and Impact - Kyndryl's stock price dropped over 54% following the announcement of the departure of the CFO and General Counsel on February 9, 2026, closing at $10.59 from $23.49 on February 6, 2026 [5]. - The company disclosed that it is reviewing its cash management practices and anticipates reporting material weaknesses in its internal control over financial reporting [5]. Group 3: Investor Actions - Kyndryl investors are encouraged to contact Kessler Topaz Meltzer & Check, LLP for a free case evaluation and to discuss their legal rights [3][9]. - Investors can choose to file for lead plaintiff status, contact the law firm for evaluation, or take no action and remain absent class members [7][8].

Philadelphia, Pennsylvania--(Newsfile Corp. - March 13, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Ramaco Resources, Inc. (NASDAQ: METC) ("Ramaco" or the "Company") on behalf of investors who purchased Ramaco securities during the period from July 31, 2025 through October 23, 2025 (the "Class Period").Investor Deadline: Investors who purchased Ramaco securities during the Class Period may, no later than March 31, 2026, seek to be ap ...